- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04368650
RhBMP-2 in Intrabony Defects - A Randomized Controlled Trial
April 29, 2020 updated by: Dr R Viswa Chandra, SVS Institute of Dental Sciences
Evaluation of Rhbmp-2 And Sticky Bone in Intrabony Defects - A Randomized Controlled Trial
This study evaluated the regenerative potential of rhBMP-2 gel in intrabony defects when compared to sticky bone (control).
Study Overview
Detailed Description
It was done in 40 subjects who were evaluated for a period of 6 months.
the results were evaluated clinically (CAL, PPD) and radiographically (bone fill) and after 6 months.
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Andhra Pradesh
-
Hyderabad, Andhra Pradesh, India, 509002
- SVS Institute of Dental Sciences, Mahabubnagar
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 55 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Systemically healthy male and female patients age 20-55 years with intrabony defects and probing pocket depth of ≥5mm after initial therapy were included in the study.
Exclusion Criteria:
- Medically compromised patients, Subjects who underwent radiotherapy or chemotherapy and smokers were excluded.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: TRIPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Main treatment group
The in situ BMP-2 gel was prepared to a concentration of approximately 0.5 μg/ml and were stored at 4oC.
The gel was then dispensed at site of interest in the study.
|
lyophilized Human Bone Morphogenetic Protein-2 was used as an active drug.
Other Names:
|
Active Comparator: Control
In patients selected for control group, after degranulation, sticky bone was used to fill the defect.
The surgical site was protected and covered using a periodontal dressing.
|
For the preparation of sticky bone, the patient's venous blood is collected and centrifuged at 2400rpm for 2min which leads to two different layers in the vacutainer the upper autologous fibrin glue (AFG) and the lower RBC portion, the upper AFG is mixed with a particulate bone graft (hydroxyapatite).
Within 5-10 min fibrin meshwork was formed
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
bone fill
Time Frame: 6 months
|
bone fill evaluation done after 6 months by using ImageJ® software
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 5, 2017
Primary Completion (Actual)
September 20, 2019
Study Completion (Actual)
October 11, 2019
Study Registration Dates
First Submitted
April 23, 2020
First Submitted That Met QC Criteria
April 29, 2020
First Posted (Actual)
April 30, 2020
Study Record Updates
Last Update Posted (Actual)
April 30, 2020
Last Update Submitted That Met QC Criteria
April 29, 2020
Last Verified
April 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SVSIDS/PERIO/4/2017
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
No plans to share IPD.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Periodontitis
-
Azienda Socio Sanitaria Territoriale degli Spedali...Università degli Studi di FerraraCompletedPeriodontitis, Aggressive | Periodontitis, AdultItaly
-
Panineeya Mahavidyalaya Institute of Dental Sciences...Research Institute for Genetic and Human TherapyUnknownGeneralized Adult Periodontitis
-
Asem Mohammed Kamel AliCompletedMolar-incisor Pattern Grade C Periodontitis ( Localized Aggressive Periodontitis) | Generalized Grade C Periodontitis (Generalized Aggressive Periodontitis)Egypt
-
Columbia UniversityCompletedPeriodontal Diseases | Generalized Moderate Chronic Periodontitis | Generalized Severe Chronic PeriodontitisUnited States
-
Postgraduate Institute of Dental Sciences RohtakUnknownChronic Apical PeriodontitisIndia
-
University of SienaNot yet recruitingPeriodontitis, AdultItaly
-
Lithuanian University of Health SciencesCompleted
-
Louisiana State University Health Sciences Center...CompletedPeriodontitis, AdultUnited States
-
University of BergenCompletedPeriodontitis | Adult Periodontitis
-
Cairo UniversityUnknownPeriodontitis, AdultEgypt
Clinical Trials on BMP-2
-
Daewoong Pharmaceutical Co. LTD.Bio-alpha Co. LTD.CompletedRegeneration of Alveolar Tissue After Maxillary Sinus Floor AugmentationKorea, Republic of
-
University of Alabama at BirminghamMedtronic; The Children's Tumor FoundationTerminatedNF1 | Congenital Pseudarthrosis of TibiaUnited States, Australia
-
Ross LeightonCanadian Orthopaedic Trauma SocietyWithdrawnNon Union Diaphyseal FracturesCanada
-
Indonesia UniversityUnknown
-
Assiut UniversityNot yet recruiting
-
BioAlpha Inc.CompletedBone Graft | Alveolar Bone Preservation
-
BioAlpha Inc.UnknownTransforaminal Lumbar Interbody Fusion
-
PfizerTerminatedRotator Cuff TearGermany, Netherlands
-
PfizerTerminatedRotator Cuff TearJapan